X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2921) 2921
Book Review (579) 579
Publication (187) 187
Newsletter (88) 88
Newspaper Article (41) 41
Book Chapter (16) 16
Book / eBook (8) 8
Conference Proceeding (7) 7
Magazine Article (3) 3
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2545) 2545
humans (2493) 2493
cytomegalovirus (1235) 1235
male (1175) 1175
female (1021) 1021
adult (1014) 1014
middle aged (752) 752
cytomegalovirus infections (711) 711
aids (665) 665
infectious diseases (662) 662
aids/hiv (657) 657
antiviral agents - therapeutic use (642) 642
virology (595) 595
immunology (594) 594
infection (590) 590
cytomegalovirus - genetics (499) 499
ganciclovir (497) 497
disease (490) 490
cytomegalovirus infections - virology (482) 482
cytomegalovirus - isolation & purification (476) 476
cytomegalovirus infections - drug therapy (467) 467
retinitis (464) 464
ophthalmology (451) 451
virus diseases (433) 433
health aspects (428) 428
infections (422) 422
ganciclovir - therapeutic use (405) 405
abridged index medicus (398) 398
transplantation (382) 382
polymerase chain reaction (372) 372
microbiology (370) 370
cytomegalovirus infections - diagnosis (367) 367
cytomegalovirus retinitis (362) 362
cytomegalovirus infections - complications (338) 338
cytomegalovirus - immunology (328) 328
animals (321) 321
hiv (312) 312
viruses (309) 309
cytomegalovirus retinitis - drug therapy (307) 307
cytomegalovirus - drug effects (305) 305
risk factors (280) 280
aged (279) 279
cytomegalovirus infections - immunology (274) 274
research (264) 264
aids-related opportunistic infections - drug therapy (261) 261
adolescent (257) 257
antiviral agents (254) 254
human cytomegalovirus (242) 242
antiviral agents - pharmacology (240) 240
retrospective studies (240) 240
aids-related opportunistic infections - virology (237) 237
diagnosis (233) 233
pharmacology & pharmacy (231) 231
viral load (231) 231
drug therapy (228) 228
dna, viral - analysis (223) 223
acquired immunodeficiency syndrome - complications (222) 222
dna (214) 214
human-immunodeficiency-virus (211) 211
foscarnet (210) 210
therapy (210) 210
cd4 lymphocyte count (204) 204
cytomegalovirus retinitis - virology (201) 201
prospective studies (201) 201
cytomegalovirus - physiology (196) 196
child (188) 188
cytomegalovirus infections - prevention & control (188) 188
virus (188) 188
antiviral agents - administration & dosage (187) 187
retinal diseases (183) 183
cytomegalovirus retinitis - diagnosis (179) 179
aids patients (176) 176
hiv infections - complications (176) 176
care and treatment (175) 175
acquired-immunodeficiency-syndrome (174) 174
active antiretroviral therapy (173) 173
hiv infections - drug therapy (165) 165
analysis (163) 163
aids-related opportunistic infections - diagnosis (158) 158
ganciclovir - administration & dosage (158) 158
cmv (152) 152
immunocompromised host (152) 152
cytomegalovirus infections - epidemiology (151) 151
treatment outcome (150) 150
medical research (149) 149
cytomegalovirus retinitis - complications (147) 147
mice (147) 147
human immunodeficiency virus--hiv (146) 146
prevention (146) 146
recipients (145) 145
polymerase-chain-reaction (142) 142
follow-up studies (141) 141
cytomegalovirus infections - etiology (140) 140
medicine, general & internal (136) 136
mortality (135) 135
transplant recipients (135) 135
hematology (134) 134
highly active antiretroviral therapy (132) 132
drug therapy, combination (129) 129
medicine & public health (129) 129
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3026) 3026
French (21) 21
Spanish (11) 11
German (4) 4
Japanese (4) 4
Chinese (2) 2
Czech (2) 2
Korean (2) 2
Italian (1) 1
Polish (1) 1
Romanian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cytokine, ISSN 1043-4666, 08/2016, Volume 84, pp. 56 - 62
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 07/2017, Volume 96, Issue 7, pp. 1215 - 1217
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00277-017-3005-y 
HEMATOLOGY | REACTIVATION | Bendamustine Hydrochloride - therapeutic use | Lymphoma, B-Cell - complications | Injections, Intravenous | Follow-Up Studies | Intravitreal Injections | Bendamustine Hydrochloride - adverse effects | Humans | Middle Aged | Neoplasm Recurrence, Local - virology | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - pathology | Cytomegalovirus Retinitis - virology | Cytomegalovirus Retinitis - drug therapy | Neoplasm Grading | Cytomegalovirus Retinitis - immunology | Aged, 80 and over | Ganciclovir - therapeutic use | Female | Lymphoma, B-Cell - virology | Opportunistic Infections - immunology | Retrospective Studies | Cytomegalovirus Retinitis - complications | Lymphoma, B-Cell - drug therapy | Opportunistic Infections - complications | Cytomegalovirus - isolation & purification | Opportunistic Infections - virology | Drug Administration Schedule | Japan | Academic Medical Centers | Antineoplastic Agents, Alkylating - therapeutic use | Cytomegalovirus - immunology | Opportunistic Infections - drug therapy | Lymphoma, B-Cell - pathology | Aged | Neoplasm Recurrence, Local - complications | Antineoplastic Agents, Alkylating - adverse effects | Ganciclovir - administration & dosage | Cytomegalovirus - drug effects | Antimitotic agents | Cytomegalovirus infections | Care and treatment | Lymphomas | Antineoplastic agents | Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 06/2014, Volume 58, Issue 12, pp. 1700 - 1706
Journal Article
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2013, Volume 155, Issue 2, pp. 206 - 212.e5
Purpose To report the incidence and clinical outcomes of non-cytomegalovirus (non-CMV) ocular opportunistic infections in patients with acquired... 
Ophthalmology | ERA | ACTIVE ANTIRETROVIRAL THERAPY | OPHTHALMOLOGY | AIDS | RISK | VISUAL-ACUITY LOSS | RETINITIS | United States - epidemiology | Visual Fields - physiology | Cytomegalovirus Retinitis - epidemiology | Prospective Studies | Mycobacterium avium-intracellulare Infection - epidemiology | Toxoplasmosis, Ocular - virology | Humans | Middle Aged | Toxoplasmosis, Ocular - epidemiology | Male | Herpes Simplex - drug therapy | Incidence | Cytomegalovirus Retinitis - virology | Cytomegalovirus Retinitis - drug therapy | Retinitis - virology | Adult | Female | Drug Therapy, Combination | Visual Acuity - physiology | Mycobacterium avium-intracellulare Infection - virology | Retinitis - epidemiology | Choroiditis - epidemiology | Antiviral Agents - therapeutic use | AIDS-Related Opportunistic Infections - drug therapy | Survival Rate | CD4 Lymphocyte Count | Antiretroviral Therapy, Highly Active | AIDS-Related Opportunistic Infections - virology | Choroiditis - drug therapy | Herpes Simplex - virology | Mycobacterium avium-intracellulare Infection - drug therapy | Retinitis - drug therapy | AIDS-Related Opportunistic Infections - epidemiology | Toxoplasmosis, Ocular - drug therapy | Choroiditis - virology | Herpes Simplex - epidemiology | Antiviral agents | HIV patients | Opportunistic infections | Health aspects | Cytomegalovirus | Infections | Drug therapy | Human immunodeficiency virus--HIV | Mortality | Public health | Index Medicus | Abridged Index Medicus
Journal Article